Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ISEE |
---|---|---|
09:32 ET | 17781 | 23.88 |
09:33 ET | 25727 | 23.585 |
09:35 ET | 1775 | 23.63 |
09:37 ET | 5315 | 23.78 |
09:39 ET | 4396 | 23.61 |
09:42 ET | 2409 | 23.795 |
09:44 ET | 19933 | 23.71 |
09:46 ET | 628 | 23.74 |
09:48 ET | 11681 | 24.05 |
09:50 ET | 8465 | 24.25 |
09:51 ET | 10729 | 24.08 |
09:53 ET | 6549 | 23.995 |
09:55 ET | 3197 | 23.945 |
09:57 ET | 2700 | 23.905 |
10:00 ET | 3380 | 23.87 |
10:02 ET | 8497 | 23.905 |
10:04 ET | 4614 | 23.71 |
10:06 ET | 7115 | 23.805 |
10:08 ET | 5400 | 23.83 |
10:09 ET | 5724 | 23.87 |
10:11 ET | 2885 | 23.8987 |
10:13 ET | 59800 | 23.82 |
10:15 ET | 7669 | 23.76 |
10:18 ET | 8539 | 23.685 |
10:20 ET | 8321 | 23.78 |
10:22 ET | 8208 | 23.73 |
10:24 ET | 7546 | 23.69 |
10:26 ET | 114357 | 23.7 |
10:27 ET | 31101 | 23.545 |
10:29 ET | 10998 | 23.53 |
10:31 ET | 23880 | 23.53 |
10:33 ET | 13481 | 23.475 |
10:36 ET | 16300 | 23.66 |
10:38 ET | 10397 | 23.79 |
10:40 ET | 13064 | 23.685 |
10:42 ET | 3861 | 23.67 |
10:44 ET | 6938 | 23.71 |
10:45 ET | 2800 | 23.76 |
10:47 ET | 6764 | 23.81 |
10:49 ET | 5161 | 23.93 |
10:51 ET | 14966 | 23.945 |
10:54 ET | 5364 | 23.98 |
10:56 ET | 2991 | 24 |
10:58 ET | 37597 | 23.8 |
11:00 ET | 12650 | 23.68 |
11:02 ET | 7221 | 23.51 |
11:03 ET | 10999 | 23.655 |
11:05 ET | 3931 | 23.76 |
11:07 ET | 17157 | 23.8 |
11:09 ET | 18002 | 23.77 |
11:12 ET | 5700 | 23.64 |
11:14 ET | 4451 | 23.6 |
11:16 ET | 1100 | 23.64 |
11:18 ET | 2200 | 23.5778 |
11:20 ET | 1500 | 23.61 |
11:21 ET | 5000 | 23.63 |
11:23 ET | 7541 | 23.605 |
11:25 ET | 7640 | 23.62 |
11:27 ET | 6326 | 23.57 |
11:30 ET | 16451 | 23.64 |
11:32 ET | 5074 | 23.635 |
11:34 ET | 8156 | 23.61 |
11:36 ET | 9485 | 23.62 |
11:38 ET | 13436 | 23.56 |
11:39 ET | 5900 | 23.57 |
11:41 ET | 23332 | 23.6154 |
11:43 ET | 12656 | 23.67 |
11:45 ET | 10581 | 23.66 |
11:48 ET | 7450 | 23.7 |
11:50 ET | 6764 | 23.78 |
11:52 ET | 51553 | 24 |
11:54 ET | 16383 | 24.04 |
11:56 ET | 14268 | 24.18 |
11:57 ET | 9817 | 24.085 |
11:59 ET | 54863 | 23.96 |
12:01 ET | 21950 | 23.915 |
12:03 ET | 9357 | 23.9 |
12:06 ET | 1300 | 23.89 |
12:08 ET | 2500 | 23.98 |
12:10 ET | 2825 | 23.96 |
12:12 ET | 3324 | 23.97 |
12:14 ET | 3699 | 23.95 |
12:15 ET | 2500 | 23.975 |
12:17 ET | 2040 | 24.02 |
12:19 ET | 2290 | 23.99 |
12:21 ET | 18106 | 23.91 |
12:24 ET | 5214 | 23.95 |
12:26 ET | 7325 | 24.105 |
12:28 ET | 6355 | 24.11 |
12:30 ET | 32524 | 24.16 |
12:32 ET | 6676 | 24.19 |
12:33 ET | 33595 | 24.25 |
12:35 ET | 10661 | 24.19 |
12:37 ET | 15597 | 24.25 |
12:39 ET | 800 | 24.315 |
12:42 ET | 11765 | 24.14 |
12:44 ET | 26440 | 24.055 |
12:46 ET | 3370 | 24.05 |
12:48 ET | 2742 | 24.025 |
12:50 ET | 39464 | 24.24 |
12:51 ET | 10633 | 24.26 |
12:53 ET | 5296 | 24.255 |
12:55 ET | 6986 | 24.215 |
12:57 ET | 12693 | 24.455 |
01:00 ET | 13190 | 24.46 |
01:02 ET | 4986 | 24.37 |
01:04 ET | 3200 | 24.405 |
01:06 ET | 14239 | 24.4557 |
01:08 ET | 9790 | 24.47 |
01:09 ET | 152798 | 24.51 |
01:11 ET | 12848 | 24.54 |
01:13 ET | 18942 | 24.43 |
01:15 ET | 4481 | 24.53 |
01:18 ET | 27367 | 24.53 |
01:20 ET | 59951 | 24.44 |
01:22 ET | 11614 | 24.32 |
01:24 ET | 25397 | 24.4022 |
01:26 ET | 15744 | 24.36 |
01:27 ET | 1577 | 24.455 |
01:29 ET | 4873 | 24.41 |
01:31 ET | 1400 | 24.47 |
01:33 ET | 3690 | 24.425 |
01:36 ET | 39086 | 24.445 |
01:38 ET | 12309 | 24.42 |
01:40 ET | 2108 | 24.32 |
01:42 ET | 2000 | 24.345 |
01:44 ET | 5820 | 24.435 |
01:45 ET | 5236 | 24.34 |
01:47 ET | 6235 | 24.38 |
01:49 ET | 3221 | 24.38 |
01:51 ET | 1432 | 24.395 |
01:54 ET | 2343 | 24.3561 |
01:56 ET | 1707 | 24.4 |
01:58 ET | 5244 | 24.385 |
02:00 ET | 9374 | 24.37 |
02:02 ET | 4381 | 24.4087 |
02:03 ET | 3867 | 24.4 |
02:05 ET | 3639 | 24.36 |
02:07 ET | 4944 | 24.37 |
02:09 ET | 8249 | 24.35 |
02:12 ET | 5918 | 24.32 |
02:14 ET | 6739 | 24.31 |
02:16 ET | 3193 | 24.31 |
02:18 ET | 86340 | 24.25 |
02:20 ET | 3206 | 24.24 |
02:21 ET | 7876 | 24.12 |
02:23 ET | 21099 | 24.09 |
02:25 ET | 8663 | 24.085 |
02:27 ET | 5486 | 24.02 |
02:30 ET | 32931 | 23.92 |
02:32 ET | 23041 | 23.785 |
02:34 ET | 23787 | 23.76 |
02:36 ET | 61361 | 23.73 |
02:38 ET | 7815 | 23.84 |
02:39 ET | 7748 | 23.64 |
02:41 ET | 3865 | 23.65 |
02:43 ET | 8987 | 23.6711 |
02:45 ET | 8878 | 23.645 |
02:48 ET | 85130 | 23.545 |
02:50 ET | 6463 | 23.63 |
02:52 ET | 2885 | 23.67 |
02:54 ET | 6832 | 23.635 |
02:56 ET | 2583 | 23.66 |
02:57 ET | 3915 | 23.64 |
02:59 ET | 3826 | 23.62 |
03:01 ET | 3906 | 23.625 |
03:03 ET | 2686 | 23.6 |
03:06 ET | 7279 | 23.625 |
03:08 ET | 23862 | 23.51 |
03:10 ET | 5717 | 23.44 |
03:12 ET | 3100 | 23.455 |
03:14 ET | 7108 | 23.52 |
03:15 ET | 3495 | 23.53 |
03:17 ET | 6200 | 23.49 |
03:19 ET | 5912 | 23.53 |
03:21 ET | 4841 | 23.6 |
03:24 ET | 92199 | 23.555 |
03:26 ET | 19492 | 23.65 |
03:28 ET | 35597 | 23.745 |
03:30 ET | 9506 | 23.645 |
03:32 ET | 7901 | 23.68 |
03:33 ET | 16213 | 23.7 |
03:35 ET | 3722 | 23.76 |
03:37 ET | 14397 | 23.755 |
03:39 ET | 5977 | 23.74 |
03:42 ET | 7413 | 23.63 |
03:44 ET | 12463 | 23.73 |
03:46 ET | 88301 | 23.76 |
03:48 ET | 8012 | 23.87 |
03:50 ET | 12920 | 23.845 |
03:51 ET | 16065 | 23.9 |
03:53 ET | 11530 | 23.855 |
03:55 ET | 23358 | 23.96 |
03:57 ET | 34416 | 23.97 |
04:00 ET | 392313 | 23.99 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
IVERIC bio Inc | 3.2B | -17.9x | --- |
Axsome Therapeutics Inc | 3.2B | -18.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,295.8x | --- |
Beam Therapeutics Inc | 3.2B | -10.7x | --- |
Vaxcyte Inc | 3.5B | -15.4x | --- |
Alvotech SA | 3.0B | 0.0x | --- |
IVERIC bio, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development ofl treatments for retinal diseases with unmet medical needs. Its lead asset clinical stage product candidate Zimura, a complement C5 inhibitor. Zimura is targeting diseases include: Geographic Atrophy (GA), intermediate (age-related macular degeneration) AMD, and autosomal recessive Stargardt disease (STGD1). It is also developing preclinical product candidate IC-500, a High temperature requirement A serine peptidase 1 protein (HtrA1) inhibitor for GA and potentially other age-related retinal diseases. Its portfolio also includes two preclinical stage gene therapy product candidates, which include IC-100 and IC-200 and several ongoing gene therapy research programs. The Company is developing IC-100 for rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for bestrophin-1 (BEST1) related IRDs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.08 |
EPS | $-1.34 |
Book Value | $3.13 |
P/E Ratio | -17.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.